NVS - ノバルティス ()


   Potassium Gluconate Market With Leading Players like Novartis AG, GlaxoSmithKline Plc, Merck and Co., Abbott Laboratories, Boehringer Ingelheim GmbH, AstraZeneca Plc, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd, Vectura Group plc, Pfizer  2020/12/28 04:08:08 OpenPR
Potassium gluconate is mineral drug therapy generally given in patients with lower potassium levels in their blood stream which is referred to as hypokalemia. Low potassium levels leads to abnormal body functions. Potassium gluconate regulates proper functioning of cells, kidney,
   Human Vaccine Market Thriving Worldwide at A Tremendous Growth: GSK, Merck, Novartis, Pfizer, Sinovac  2020/12/24 17:05:37 OpenPR
Global Human Vaccine Market Research Report 2020 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development,
   Autism Disorder and Treatment Market Booming Segments; Investors Seeking Growth 2027 - AbbVie, Eli Lilly, Abbott, Novartis AGP, Coronis Neurosciences and GlaxoSmithKline  2020/12/19 12:59:13 OpenPR
Worldwide Autism Disorder and Treatment Market Analysis to 2027 is a specialized and in-depth study of the Autism Disorder and Treatment Industry with a focus on the global market trend. The report aims to provide an overview of global Autism
   Clinical Trials Management System Market to Witness Phenomena Growth by 2021-2026 | Roche, Novartis, Pfizer, Merck  2020/12/19 12:49:05 OpenPR
A new business intelligence report released by HTF MI with title "Global Clinical Trials Management System Market Size, Status and Forecast 2021-2026" is designed covering micro level of analysis by manufacturers and key business segments. The Global Clinical Trials Management
   Amgen – International Chemotherapy-Induced Neutropenia Remedy Market 2020 Latest Growth – Amgen, Sanofi, Novartis AG, Ba  2020/12/19 05:37:30 Fintech Zoom
Amgen - International Chemotherapy-Induced Neutropenia Remedy Market 2020 Latest Growth – Amgen, Sanofi, Novartis AG, Baxter Worldwide – BIZNEWS -
   Systemic Aspergillosis and Systemic Candidasis Market With Leading Players like Novartis AG, Sanofi-Aventis, Pfizer, Merck and Company, Enzon Pharmaceuticals, Bayer AG, Astellas Pharma, GlaxoSmithKline, Abbott, Cipla  2020/12/18 12:00:31 OpenPR
The Systemic Aspergillosis and Systemic Candidiasis are the type of fungal infections. The aspergillosis infection is caused by molds and majorly affect the respiratory tract of an individual. The aspergillosis is not a severe condition but people with weakened immune
   Global Combination Antibody Therapy Market Report (2020-2027) | The demand for the Market will drastically increase in the Future|| Eli Lilly and Company, Novartis AG, Genetech Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd  2020/12/17 19:05:06 OpenPR
“Global Combination Antibody Therapy Market–Industry Trends and Forecast to 2027” focuses on the major drivers and limitations for the key players top key players and new comers in industry, competitive landscape, sales, price, revenue, gross margin, market share, market risks,
   Global Candida Infections Drugs Market Industry Is Growing At A Rapid Pace|| Abbott, Pfizer Inc., Novartis AG, Merck & Co., Inc, Sanofi, Bayer AG, Astellas Pharma Inc  2020/12/17 18:52:49 OpenPR
“Global Candida Infections Drugs Market- Industry Trends and Forecast to 2027” Worldwide Industry Size, Offer and trends analysis during Period. Candida Infections Drugs Market report is a thoughtful analysis of the market presenting the propelled situation in the market and
   Global Biologics Market 2020-2027:Competitive landscape By Merck & Co., Inc., Roche AG, AstraZeneca Plc, Regeneron Pharmaceuticals, Inc, Novartis International AG, Pfizer, Inc., Amgen, Inc  2020/12/17 18:43:14 OpenPR
“Global Biologics Market–Industry Trends and Forecast to 2027” focuses on the major drivers and limitations for the key players. These research report also provides Comprehensive analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The
   Global Gene Therapy Market Report 2020-2030 Featuring Novartis, Bluebird Bio, Spark Therapeutics, Audentes Therapeutics, Voyager Therapeutics, UniQure, Celgene, Cellectis and Sangamo Therapeutics  2020/12/17 17:00:00 PR Newswire
DUBLIN, Dec. 17, 2020 /PRNewswire/ -- The "Gene Therapy Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. Gene Therapy Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and…
   Global Alzheimer’s disease Market Growth, Size, Opportunity, Share and Forecast 2020-2027||Top Leaders-Pfizer Inc, Novartis AG, F. Hoffmann-La Roche Ltd, Eisai Co., Ltd, Allergan, Teva Pharmaceutical Industries Ltd  2020/12/04 19:04:57 OpenPR
This Alzheimer’s disease report provides complete analysis of the market on global and regional level. It inspects the development rate and the market value dependent on the market elements and growth initiating factors. The market players are
   Big pharma is using AI and machine learning in drug discovery and development to save lives  2020/12/04 18:00:00 Business Insider
Summary List Placement The pharmaceutical industry has been slow-moving when it comes to adopting digital health technology, and pharma companies overall have taken a long time to implement AI and machine learning strategies — making broad-scale digital transformation difficult. There is ample opportunity for drug discovery and development, but it relies on the ability of companies to implement advanced health tech into everyday strategies. While the healthcare industry is rapidly adopting digital tech, the pharma industry is lagging on digital maturity, and any measures even early movers are taking to catch up are patchworked due to a lack of strategy and digital-focused leadership. AI & Machine Learning in the Drug Development Process An incredible amount of time and money goes into drug development — bringing a drug to market costs about $2.8 billion dollars over 12+ years, according to Taconic Biosciences' tally. Utilizing AI and machine learning can help at every stage of the drug discovery process.
   Anti-malarial Drugs Market Insights 2020 | Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG  2020/12/04 08:03:55 OpenPR
Malaria has affected the tropical regions in the world including Africa and Asia, Central and South America, Haiti and the Dominican Republic, some parts of Middle East, and some Pacific islands. The increasing cases of traveler’s malaria is one of
   Pediatric Palliative Care Drugs Market 2020: Industry Size & Share, Business Strategies | Novartis International AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals  2020/12/04 07:47:46 OpenPR
Pediatric palliative care is a specialized medical care for infants and children living with serious medical conditions such as cancer, genetic disorders, prematurity, heart and lung conditions, neurologic disorders, and others. The goal of palliative care is to improve quality
   Lark Health partnered with Highmark as digital therapy makers continue riding the digital health wave  2020/12/03 14:53:23 Business Insider
Summary List Placement Lark Health partnered with Highmark—the 4th largest BCBS-affiliated organization—to give Highmark members 24/7 access to Lark Health's digital therapeutics (DTx) programs for hypertension and diabetes. DTx companies have been capturing the attention of pharma companies and payers this year: Pharma cos have been strategically pouring cash into DTx firms to capture a slice of the growing DTx market. For example, Boehringer Ingelheim signed a $500 million contract with Click Therapeutics to develop therapies for psychiatric conditions, Bayer invested $100 million in equity stake of digital diabetes startup OneDrop, and Novartis acquired ophthalmology DTx startup Amblyotech. And with the FDA greenlighting multiple DTx treatments—like Akili's ADHD therapy and Pear's schizophrenia program—pharma companies can invest in DTx solutions with more confidence that they'll see an ROI. Payers are wading deeper into the DTx space to pare down their shares of high costs for members with chronic conditions.